Neutralization antibody titers against SARS-CoV-2 in an infant born to a mother with COVID-19
暂无分享,去创建一个
C. Chiu | Yu-An Kung | S. Shih | Jeng-Chang Chen | R. Lien | R. Janapatla | Yi-Ching Chen | M-H Hsu
[1] Jeffrey S. Morris,et al. Assessment of Maternal and Neonatal Cord Blood SARS-CoV-2 Antibodies and Placental Transfer Ratios. , 2021, JAMA pediatrics.
[2] Jesse M. Fajnzylber,et al. Assessment of Maternal and Neonatal SARS-CoV-2 Viral Load, Transplacental Antibody Transfer, and Placental Pathology in Pregnancies During the COVID-19 Pandemic , 2020, JAMA network open.
[3] M. Stockwell,et al. Outcomes of Neonates Born to Mothers With Severe Acute Respiratory Syndrome Coronavirus 2 Infection at a Large Medical Center in New York City. , 2020, JAMA pediatrics.
[4] R. Coffman,et al. Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19 , 2020, Scientific Reports.
[5] Nguyen H. Tran,et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial , 2020, The Lancet.
[6] Yuan Wang,et al. Clinical characteristics of novel coronavirus disease 2019 (COVID-19) in newborns, infants and children , 2020, Pediatrics & Neonatology.
[7] C. Chiu,et al. SARS-CoV-2 infection in children: Transmission dynamics and clinical characteristics , 2020, Journal of the Formosan Medical Association.
[8] C. Chiu,et al. SARS-CoV-2 genomic surveillance in Taiwan revealed novel ORF8-deletion mutant and clade possibly associated with infections in Middle East , 2020, Emerging microbes & infections.